Filing Details
- Accession Number:
- 0001209191-20-042897
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-17 17:05:14
- Reporting Period:
- 2020-07-15
- Accepted Time:
- 2020-07-17 17:05:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1746298 | Scott Richard Struthers | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-07-15 | 17,500 | $15.30 | 908,305 | No | 4 | S | Indirect | By Family Trust 1 |
Common Stock | Disposition | 2020-07-16 | 17,500 | $14.46 | 890,805 | No | 4 | S | Indirect | By Family Trust 1 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Family Trust 1 |
No | 4 | S | Indirect | By Family Trust 1 |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 100,000 | Indirect | By Family Trust 2 |
Common Stock | 100,000 | Indirect | By Family Trust 3 |
Common Stock | 100,000 | Indirect | By Family Trust 4 |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $14.95 and $15.76 per share. Information on the exact number of shares sold at each price can be obtained from the issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $14.10 and $15.34 per share. Information on the exact number of shares sold at each price can be obtained from the issuer upon request.